154 related articles for article (PubMed ID: 36074137)
1. Selective local postoperative radiotherapy for T3-T4 N0 laryngeal cancer.
Dağdelen M; Şahin M; Çatal TK; Yıldırım HC; Karaçam SÇ; Çepni K; Uzel ÖE
Strahlenther Onkol; 2022 Nov; 198(11):1025-1031. PubMed ID: 36074137
[TBL] [Abstract][Full Text] [Related]
2. Elective neck dissection in the treatment of T3/T4 N0 squamous cell carcinoma of the larynx.
Kligerman J; Olivatto LO; Lima RA; Freitas EQ; Soares JR; Dias FL; Melo LE; Sá GM; Duccini E
Am J Surg; 1995 Nov; 170(5):436-9. PubMed ID: 7485727
[TBL] [Abstract][Full Text] [Related]
3. Nodal metastases distribution in laryngeal cancer requiring total laryngectomy: Therapeutic implications for the N0 Neck.
Riviere D; Mancini J; Santini L; Loth Bouketala A; Giovanni A; Dessi P; Fakhry N
Eur Ann Otorhinolaryngol Head Neck Dis; 2019 Jun; 136(3S):S35-S38. PubMed ID: 30174259
[TBL] [Abstract][Full Text] [Related]
4. Treatment results and prognostic factors of advanced T3--4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience.
Nguyen-Tan PF; Le QT; Quivey JM; Singer M; Terris DJ; Goffinet DR; Fu KK
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1172-80. PubMed ID: 11483326
[TBL] [Abstract][Full Text] [Related]
5. [Clinical analysis of relevant factors causing postoperative recurrence of laryngeal cancer after partial laryngectomy].
Liu C; Xu ZG
Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):377-81. PubMed ID: 24054016
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of laryngectomy alone for treatment of locally advanced laryngeal cancer: A stage- and subsite-specific survival analysis.
Cervenka BP; Rao S; Farwell DG; Bewley AF
Clin Otolaryngol; 2018 Apr; 43(2):544-552. PubMed ID: 29054118
[TBL] [Abstract][Full Text] [Related]
7. [Postoperative radiotherapy in N0 laryngeal cancer].
Maillard S; Jovenin N; Cauchois A; Froissart D; Merol JC; Chays A; Nguyen TD
Cancer Radiother; 2005 Sep; 9(5):285-92. PubMed ID: 16168697
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy for the clinically negative neck in supraglottic laryngeal cancer.
Alpert TE; Morbidini-Gaffney S; Chung CT; Bogart JA; Hahn SS; Hsu J; Kellman RM
Cancer J; 2004; 10(6):335-8. PubMed ID: 15701263
[TBL] [Abstract][Full Text] [Related]
9. Total laryngectomy and postoperative radiotherapy for T4 laryngeal cancer: a 14-year review.
Ampil FL; Nathan CO; Caldito G; Lian TF; Aarstad RF; Krishnamsetty RM
Am J Otolaryngol; 2004; 25(2):88-93. PubMed ID: 14976652
[TBL] [Abstract][Full Text] [Related]
10. Local control after supracricoid partial laryngectomy for "advanced" endolaryngeal squamous cell carcinoma classified as T3.
Dufour X; Hans S; De Mones E; Brasnu D; Ménard M; Laccourreye O
Arch Otolaryngol Head Neck Surg; 2004 Sep; 130(9):1092-9. PubMed ID: 15381597
[TBL] [Abstract][Full Text] [Related]
11. [Timing and duration of postoperative radiotherapy in patients with laryngeal cancer].
Milecki P; Kruk-Zagajewska A; Stryczyńska G
Otolaryngol Pol; 2002; 56(3):307-11. PubMed ID: 12162018
[TBL] [Abstract][Full Text] [Related]
12. Oncological outcomes of surgical treatment for T3 supraglottic laryngeal squamous cell carcinoma patients.
Zhou J; Zhou L; Tao L; Zhang M; Wu H; Chen X; Li X; Li C; Gong H
Acta Otolaryngol; 2018 Nov; 138(11):1028-1034. PubMed ID: 30735065
[TBL] [Abstract][Full Text] [Related]
13. Neo-adjuvant chemotherapy and supracricoid partial laryngectomy with cricohyoidopexy for advanced endolaryngeal carcinoma classified as T3-T4: 5-year oncologic results.
Laccourreye O; Brasnu D; Biacabe B; Hans S; Seckin S; Weinstein G
Head Neck; 1998 Oct; 20(7):595-9. PubMed ID: 9744458
[TBL] [Abstract][Full Text] [Related]
14. Laryngeal long-term morbidity after supraglottic laryngectomy and postoperative radiation therapy.
Spriano G; Antognoni P; Sanguineti G; Sormani M; Richetti A; Ameli F; Piantanida R; Luraghi R; Magli A; Corvo R; Tordiglione M; Vitale V
Am J Otolaryngol; 2000; 21(1):14-21. PubMed ID: 10668672
[TBL] [Abstract][Full Text] [Related]
15. [Surgical management and preservation of laryngeal function for senile patients with advanced laryngeal carcinoma].
Zhang DG; Zhang HB; Luan XY; Pan XL; Xie G
Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):379-81. PubMed ID: 17892137
[TBL] [Abstract][Full Text] [Related]
16. Significance of laryngeal edema after partial laryngectomy and radiotherapy in supraglottic cancer.
Oksüz DC; Uzel O; Yildirim A; Yetmen O; Sahinler I; Turkan S
J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):681-8. PubMed ID: 19128676
[TBL] [Abstract][Full Text] [Related]
17. [Stomal recurrence after total laryngectomy].
Szyfter W; Kruk-Zagajewska A; Borucki L; Gawecki W; Milecki P
Otolaryngol Pol; 2006; 60(2):149-55. PubMed ID: 16903329
[TBL] [Abstract][Full Text] [Related]
18. Oncologic outcomes of surgical treatment for T3 glottic laryngeal squamous cell carcinoma.
Zhou J; Zhou L; Tao L; Zhang M; Wu H; Chen X; Li X; Li C; Gong H
Head Neck; 2018 Aug; 40(8):1734-1742. PubMed ID: 29601122
[TBL] [Abstract][Full Text] [Related]
19. Postoperative irradiation in patients with pT3-4N0 laryngeal cancer: results and prognostic factors.
Skóra T; Nowak-Sadzikowska J; Mucha-Małecka A; Szyszka-Charewicz B; Jakubowicz J; Gliński B
Eur Arch Otorhinolaryngol; 2015 Mar; 272(3):673-9. PubMed ID: 25432639
[TBL] [Abstract][Full Text] [Related]
20. Occult Nodal Disease Prevalence and Distribution in Recurrent Laryngeal Cancer Requiring Salvage Laryngectomy.
Birkeland AC; Rosko AJ; Issa MR; Shuman AG; Prince ME; Wolf GT; Bradford CR; McHugh JB; Brenner JC; Spector ME
Otolaryngol Head Neck Surg; 2016 Mar; 154(3):473-9. PubMed ID: 26884365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
